Relapsing Polychondritis (Airway Involvement)

1. Executive Overview: Relapsing Polychondritis and the Airways

Relapsing Polychondritis (RP) is a rare, systemic, autoimmune inflammatory condition characterized by recurrent, episodic inflammation of cartilaginous structures throughout the body. While it commonly affects the ears, nose, and joints, Airway Involvement represents the most critical and potentially life-threatening manifestation of the disease.

When RP affects the tracheobronchial tree, it leads to chondritis—inflammation of the cartilage—resulting in airway wall thickening, stenosis (narrowing), and collapse. Given that the airway is a vital structure, airway involvement in RP is the leading cause of morbidity and mortality in these patients. Early recognition by pulmonologists and rheumatologists is essential to prevent permanent structural damage and respiratory failure.

2. Pathophysiology, Etiology, and Risk Factors

The Pathophysiological Mechanism

The fundamental pathology of Relapsing Polychondritis involves an aberrant immune response directed against type II collagen and other cartilaginous proteins (such as matrilin-1).

• Autoimmune Cascade: The immune system produces autoantibodies and T-cell-mediated responses that infiltrate cartilaginous tissues.
• Enzymatic Degradation: Pro-inflammatory cytokines (TNF-alpha, IL-1, IL-6) trigger the release of matrix metalloproteinases (MMPs), which degrade the proteoglycan and collagen matrix of the cartilage.
• Airway Specificity: In the tracheobronchial tree, this degradation leads to the loss of structural integrity. As the cartilage softens (tracheomalacia), the airway walls lose their rigidity, leading to dynamic collapse during respiration, particularly during expiration.

Etiology and Risk Factors

RP is classified as an idiopathic autoimmune disease. While the exact trigger remains unknown, it is frequently associated with other autoimmune conditions, suggesting a shared genetic predisposition (specifically the HLA-DR4 allele).

3. Signs, Symptoms, and Clinical Presentation

The clinical presentation of airway-involved RP is often insidious but can progress to acute respiratory emergency.

Common Symptoms

• Dyspnea: Progressive shortness of breath, often misdiagnosed as asthma or COPD.
• Chronic Cough: Frequently non-productive and persistent.
• Stridor: A high-pitched whistling sound during breathing, indicating significant subglottic or tracheal narrowing.
• Hoarseness: Suggests laryngeal involvement (laryngitis).
• Wheezing: Often unresponsive to standard bronchodilator therapy.

Physical Exam Findings

• Tenderness over the trachea: Palpable pain over the cartilaginous rings.
• "Saddle-nose" deformity: A hallmark sign indicating cartilaginous collapse of the nasal bridge.
• Auricular chondritis: Red, swollen, and painful ears (sparing the earlobe, which is non-cartilaginous).

4. Standard Diagnostic Evaluation & Workup

Diagnosing RP requires a high index of clinical suspicion, as there is no single "gold standard" laboratory test. The McAdam’s criteria or the revised Damiani and Levine criteria are typically used for clinical diagnosis.

Imaging Modalities

• CT Chest (High Resolution): The gold standard for identifying airway involvement. It reveals tracheal wall thickening, calcification, and narrowing.
• Dynamic CT: Performed during both inspiration and expiration to evaluate for tracheobronchomalacia (airway collapse).
• PET/CT: Highly sensitive for detecting active inflammation in the cartilaginous structures before structural damage becomes irreversible.

Laboratory Assays

• Inflammatory Markers: Elevated ESR (Erythrocyte Sedimentation Rate) and CRP (C-Reactive Protein) are common during flares.
• Serology: Testing for anti-type II collagen antibodies (though sensitivity/specificity is low).
• Autoimmune Panel: To rule out concurrent conditions (ANA, ANCA, RF).

Biopsy

While clinical diagnosis is often sufficient, a biopsy of the cartilage (e.g., ear or trachea) can confirm the diagnosis by showing perichondritis, loss of basophilic staining, and inflammatory cell infiltration. However, tracheal biopsy is invasive and carries significant risks of worsening stenosis.

5. Therapeutic Interventions

Management is centered on aggressive immunosuppression to halt the inflammatory process and surgical intervention to manage structural airway complications.

Pharmacotherapy

1. Corticosteroids: The first-line therapy. High-dose systemic steroids (Prednisone or IV Methylprednisolone) are used to induce remission in acute flares.
2. Disease-Modifying Antirheumatic Drugs (DMARDs): Used as steroid-sparing agents. Methotrexate is the most commonly utilized.
3. Biologics: For refractory cases, TNF-alpha inhibitors (Infliximab, Adalimumab) or IL-6 inhibitors (Tocilizumab) have shown significant efficacy.
4. Cyclophosphamide: Reserved for severe, life-threatening airway disease with rapid, progressive narrowing.

Surgical & Interventional Procedures

• Airway Stenting: Used to maintain airway patency in cases of severe malacia or stenosis.
• Tracheostomy: May be required in emergency situations where the airway is acutely compromised.
• Airway Reconstruction: Surgical resection of the narrowed segment can be performed in stable patients, though this is high-risk due to the underlying systemic disease.

6. Massive FAQ Section

1. Is Relapsing Polychondritis considered a form of cancer?
No. It is an autoimmune disease, not a malignancy. However, it can be associated with myelodysplastic syndrome (MDS) in some elderly patients.

2. Can airway involvement in RP be cured?
There is no "cure," but the condition can be managed into long-term remission with aggressive immunosuppressive therapy.

3. What is the difference between stenosis and malacia?
Stenosis is a narrowing due to fibrosis/scarring, while malacia is the weakening of the cartilage causing the airway to collapse during breathing.

4. How often do I need follow-up appointments?
Patients with airway involvement require frequent monitoring (every 3–6 months) via PFTs (Pulmonary Function Tests) and imaging to track airway caliber.

5. Are there specific triggers for an RP flare?
While triggers are not always clear, physical trauma, infections, and surgery can sometimes precipitate a flare in cartilaginous tissues.

6. Can I live a normal life with this diagnosis?
Yes, with early diagnosis and strict adherence to a treatment regimen, most patients maintain a good quality of life.

7. Why is my asthma medication not working?
If your wheezing is caused by airway structural collapse (malacia) rather than bronchospasm, standard inhalers will not provide relief.

8. Is Relapsing Polychondritis hereditary?
It is not directly inherited, but there is a genetic predisposition. It is very rare for multiple family members to be affected.

9. What is the role of a pulmonologist in my care?
The pulmonologist is essential for monitoring airway patency, performing bronchoscopies, and managing respiratory symptoms in conjunction with the rheumatologist.

10. What is the prognosis if the airway is involved?
The prognosis depends on early intervention. Without treatment, airway collapse can be fatal. With modern immunosuppression, the prognosis has significantly improved.

Disclaimer: This guide is for educational purposes only. If you suspect you have Relapsing Polychondritis, consult a board-certified rheumatologist or pulmonologist immediately. Do not alter medication regimens without medical supervision.